Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants
A record number of 39 209 HSCT in 34 809 patients (14 950 allogeneic (43%) and 19 859 autologous (57%)) were reported by 658 centers in 48 countries to the 2013 survey. Trends include: more growth in allogeneic than in autologous HSCT, increasing use of sibling and unrelated donors and a pronounced...
Gespeichert in:
| Veröffentlicht in: | Bone marrow transplantation (Basingstoke) 2015-04, Vol.50 (4), p.476-482 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 482 |
|---|---|
| container_issue | 4 |
| container_start_page | 476 |
| container_title | Bone marrow transplantation (Basingstoke) |
| container_volume | 50 |
| creator | Passweg, J R Baldomero, H Bader, P Bonini, C Cesaro, S Dreger, P Duarte, R F Dufour, C Falkenburg, J H F Farge-Bancel, D Gennery, A Kröger, N Lanza, F Nagler, A Sureda, A Mohty, M |
| description | A record number of 39 209 HSCT in 34 809 patients (14 950 allogeneic (43%) and 19 859 autologous (57%)) were reported by 658 centers in 48 countries to the 2013 survey. Trends include: more growth in allogeneic than in autologous HSCT, increasing use of sibling and unrelated donors and a pronounced increase in haploidentical family donors when compared with cord blood donors for those patients without a matched related or unrelated donor. Main indications were leukemias, 11 190 (32%; 96% allogeneic); lymphoid neoplasias, 19 958 (57%; 11% allogeneic); solid tumors, 1543 (4%; 4% allogeneic); and nonmalignant disorders, 1975 (6%; 91% allogeneic). In patients without a matched sibling or unrelated donor, alternative donors are used. Since 2010 there has been a marked increase of 96% in the number of transplants performed from haploidentical relatives (802 in 2010 to 1571 in 2013), whereas the number of unrelated cord blood transplants has slightly decreased (789 in 2010 to 666 in 2013). The use of donor type varies greatly throughout Europe. |
| doi_str_mv | 10.1038/bmt.2014.312 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4387247</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A409833521</galeid><sourcerecordid>A409833521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c678t-33664cc6a3f54e0dd2f3c49fdd31dbc6ccf88235853cdeb91bec0b4e9f686a43</originalsourceid><addsrcrecordid>eNqNksFu1DAURSMEokNhxxpZQkIsmCGOHcdmgVSNCkWqxILZW479MnGV2MF2WvEffDAO05YpYsEqi3d8nPt8i-IlLje4JPx9O6ZNVWK6Ibh6VKwwbdi6Jqx-XKzKivE1IUycFM9ivCozRcv6aXFS1YxWDcOr4ucFjCr5yVtIVqNv2x2yDp3PwU-AspZ8QAE0uIRSAGfiMk09oDkC8h1SQ4LgVLLXgIx3PkQUe39j3R6NPgDq1TR4a_J5q9Vwh7RzQh3cQEDaB4PawXuT_crFaVAuxefFk04NEV7cfk-L3afz3fZiffn185ft2eVas4anJRmjWjNFuppCaUzVEU1FZwzBptVM647zitS8JtpAK3ALumwpiI5xpig5LT4etNPcjmCWlEENcgp2VOGH9MrKhxNne7n315IS3lS0yYK3t4Lgv88Qkxxt1DDkEODnKDHjhFDBmfgPlAlal0LgjL7-C73yc17y8JtqRE0qzv9QezWAtK7z-Rf1IpVntBT54rpaXG-OqB7ye_XRD3Oy3sWH4LsDqIOPMUB3vwZcyqVnMvdMLj2TuWcZf3W8unv4rlgZWB-AmEduD-EoxL-EvwB6_N5S</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1667953288</pqid></control><display><type>article</type><title>Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Nature</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Passweg, J R ; Baldomero, H ; Bader, P ; Bonini, C ; Cesaro, S ; Dreger, P ; Duarte, R F ; Dufour, C ; Falkenburg, J H F ; Farge-Bancel, D ; Gennery, A ; Kröger, N ; Lanza, F ; Nagler, A ; Sureda, A ; Mohty, M</creator><creatorcontrib>Passweg, J R ; Baldomero, H ; Bader, P ; Bonini, C ; Cesaro, S ; Dreger, P ; Duarte, R F ; Dufour, C ; Falkenburg, J H F ; Farge-Bancel, D ; Gennery, A ; Kröger, N ; Lanza, F ; Nagler, A ; Sureda, A ; Mohty, M ; European Society for Blood and Marrow Transplantation (EBMT) ; for the European Society for Blood and Marrow Transplantation (EBMT)</creatorcontrib><description>A record number of 39 209 HSCT in 34 809 patients (14 950 allogeneic (43%) and 19 859 autologous (57%)) were reported by 658 centers in 48 countries to the 2013 survey. Trends include: more growth in allogeneic than in autologous HSCT, increasing use of sibling and unrelated donors and a pronounced increase in haploidentical family donors when compared with cord blood donors for those patients without a matched related or unrelated donor. Main indications were leukemias, 11 190 (32%; 96% allogeneic); lymphoid neoplasias, 19 958 (57%; 11% allogeneic); solid tumors, 1543 (4%; 4% allogeneic); and nonmalignant disorders, 1975 (6%; 91% allogeneic). In patients without a matched sibling or unrelated donor, alternative donors are used. Since 2010 there has been a marked increase of 96% in the number of transplants performed from haploidentical relatives (802 in 2010 to 1571 in 2013), whereas the number of unrelated cord blood transplants has slightly decreased (789 in 2010 to 666 in 2013). The use of donor type varies greatly throughout Europe.</description><identifier>ISSN: 0268-3369</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/bmt.2014.312</identifier><identifier>PMID: 25642761</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/699/1541/1990 ; 692/700 ; Allografts ; Autografts ; Bone marrow ; Care and treatment ; Cell Biology ; Cord Blood Stem Cell Transplantation ; Databases, Factual ; Europe - epidemiology ; Female ; Forecasts and trends ; Hematology ; Hematopoietic Stem Cell Transplantation ; Humans ; Internal Medicine ; Leukemia ; Male ; Medicine ; Medicine & Public Health ; Methods ; Neoplasms - epidemiology ; Neoplasms - therapy ; Public Health ; Special Report ; Stem cell transplantation ; Stem Cells ; Surveys ; Tissue donation ; Unrelated Donors</subject><ispartof>Bone marrow transplantation (Basingstoke), 2015-04, Vol.50 (4), p.476-482</ispartof><rights>The Author(s) 2015</rights><rights>COPYRIGHT 2015 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Apr 2015</rights><rights>Copyright © 2015 Macmillan Publishers Limited 2015 Macmillan Publishers Limited</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c678t-33664cc6a3f54e0dd2f3c49fdd31dbc6ccf88235853cdeb91bec0b4e9f686a43</citedby><cites>FETCH-LOGICAL-c678t-33664cc6a3f54e0dd2f3c49fdd31dbc6ccf88235853cdeb91bec0b4e9f686a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/bmt.2014.312$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/bmt.2014.312$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25642761$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Passweg, J R</creatorcontrib><creatorcontrib>Baldomero, H</creatorcontrib><creatorcontrib>Bader, P</creatorcontrib><creatorcontrib>Bonini, C</creatorcontrib><creatorcontrib>Cesaro, S</creatorcontrib><creatorcontrib>Dreger, P</creatorcontrib><creatorcontrib>Duarte, R F</creatorcontrib><creatorcontrib>Dufour, C</creatorcontrib><creatorcontrib>Falkenburg, J H F</creatorcontrib><creatorcontrib>Farge-Bancel, D</creatorcontrib><creatorcontrib>Gennery, A</creatorcontrib><creatorcontrib>Kröger, N</creatorcontrib><creatorcontrib>Lanza, F</creatorcontrib><creatorcontrib>Nagler, A</creatorcontrib><creatorcontrib>Sureda, A</creatorcontrib><creatorcontrib>Mohty, M</creatorcontrib><creatorcontrib>European Society for Blood and Marrow Transplantation (EBMT)</creatorcontrib><creatorcontrib>for the European Society for Blood and Marrow Transplantation (EBMT)</creatorcontrib><title>Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants</title><title>Bone marrow transplantation (Basingstoke)</title><addtitle>Bone Marrow Transplant</addtitle><addtitle>Bone Marrow Transplant</addtitle><description>A record number of 39 209 HSCT in 34 809 patients (14 950 allogeneic (43%) and 19 859 autologous (57%)) were reported by 658 centers in 48 countries to the 2013 survey. Trends include: more growth in allogeneic than in autologous HSCT, increasing use of sibling and unrelated donors and a pronounced increase in haploidentical family donors when compared with cord blood donors for those patients without a matched related or unrelated donor. Main indications were leukemias, 11 190 (32%; 96% allogeneic); lymphoid neoplasias, 19 958 (57%; 11% allogeneic); solid tumors, 1543 (4%; 4% allogeneic); and nonmalignant disorders, 1975 (6%; 91% allogeneic). In patients without a matched sibling or unrelated donor, alternative donors are used. Since 2010 there has been a marked increase of 96% in the number of transplants performed from haploidentical relatives (802 in 2010 to 1571 in 2013), whereas the number of unrelated cord blood transplants has slightly decreased (789 in 2010 to 666 in 2013). The use of donor type varies greatly throughout Europe.</description><subject>692/699/1541/1990</subject><subject>692/700</subject><subject>Allografts</subject><subject>Autografts</subject><subject>Bone marrow</subject><subject>Care and treatment</subject><subject>Cell Biology</subject><subject>Cord Blood Stem Cell Transplantation</subject><subject>Databases, Factual</subject><subject>Europe - epidemiology</subject><subject>Female</subject><subject>Forecasts and trends</subject><subject>Hematology</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Leukemia</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Methods</subject><subject>Neoplasms - epidemiology</subject><subject>Neoplasms - therapy</subject><subject>Public Health</subject><subject>Special Report</subject><subject>Stem cell transplantation</subject><subject>Stem Cells</subject><subject>Surveys</subject><subject>Tissue donation</subject><subject>Unrelated Donors</subject><issn>0268-3369</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNksFu1DAURSMEokNhxxpZQkIsmCGOHcdmgVSNCkWqxILZW479MnGV2MF2WvEffDAO05YpYsEqi3d8nPt8i-IlLje4JPx9O6ZNVWK6Ibh6VKwwbdi6Jqx-XKzKivE1IUycFM9ivCozRcv6aXFS1YxWDcOr4ucFjCr5yVtIVqNv2x2yDp3PwU-AspZ8QAE0uIRSAGfiMk09oDkC8h1SQ4LgVLLXgIx3PkQUe39j3R6NPgDq1TR4a_J5q9Vwh7RzQh3cQEDaB4PawXuT_crFaVAuxefFk04NEV7cfk-L3afz3fZiffn185ft2eVas4anJRmjWjNFuppCaUzVEU1FZwzBptVM647zitS8JtpAK3ALumwpiI5xpig5LT4etNPcjmCWlEENcgp2VOGH9MrKhxNne7n315IS3lS0yYK3t4Lgv88Qkxxt1DDkEODnKDHjhFDBmfgPlAlal0LgjL7-C73yc17y8JtqRE0qzv9QezWAtK7z-Rf1IpVntBT54rpaXG-OqB7ye_XRD3Oy3sWH4LsDqIOPMUB3vwZcyqVnMvdMLj2TuWcZf3W8unv4rlgZWB-AmEduD-EoxL-EvwB6_N5S</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Passweg, J R</creator><creator>Baldomero, H</creator><creator>Bader, P</creator><creator>Bonini, C</creator><creator>Cesaro, S</creator><creator>Dreger, P</creator><creator>Duarte, R F</creator><creator>Dufour, C</creator><creator>Falkenburg, J H F</creator><creator>Farge-Bancel, D</creator><creator>Gennery, A</creator><creator>Kröger, N</creator><creator>Lanza, F</creator><creator>Nagler, A</creator><creator>Sureda, A</creator><creator>Mohty, M</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150401</creationdate><title>Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants</title><author>Passweg, J R ; Baldomero, H ; Bader, P ; Bonini, C ; Cesaro, S ; Dreger, P ; Duarte, R F ; Dufour, C ; Falkenburg, J H F ; Farge-Bancel, D ; Gennery, A ; Kröger, N ; Lanza, F ; Nagler, A ; Sureda, A ; Mohty, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c678t-33664cc6a3f54e0dd2f3c49fdd31dbc6ccf88235853cdeb91bec0b4e9f686a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>692/699/1541/1990</topic><topic>692/700</topic><topic>Allografts</topic><topic>Autografts</topic><topic>Bone marrow</topic><topic>Care and treatment</topic><topic>Cell Biology</topic><topic>Cord Blood Stem Cell Transplantation</topic><topic>Databases, Factual</topic><topic>Europe - epidemiology</topic><topic>Female</topic><topic>Forecasts and trends</topic><topic>Hematology</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Leukemia</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Methods</topic><topic>Neoplasms - epidemiology</topic><topic>Neoplasms - therapy</topic><topic>Public Health</topic><topic>Special Report</topic><topic>Stem cell transplantation</topic><topic>Stem Cells</topic><topic>Surveys</topic><topic>Tissue donation</topic><topic>Unrelated Donors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Passweg, J R</creatorcontrib><creatorcontrib>Baldomero, H</creatorcontrib><creatorcontrib>Bader, P</creatorcontrib><creatorcontrib>Bonini, C</creatorcontrib><creatorcontrib>Cesaro, S</creatorcontrib><creatorcontrib>Dreger, P</creatorcontrib><creatorcontrib>Duarte, R F</creatorcontrib><creatorcontrib>Dufour, C</creatorcontrib><creatorcontrib>Falkenburg, J H F</creatorcontrib><creatorcontrib>Farge-Bancel, D</creatorcontrib><creatorcontrib>Gennery, A</creatorcontrib><creatorcontrib>Kröger, N</creatorcontrib><creatorcontrib>Lanza, F</creatorcontrib><creatorcontrib>Nagler, A</creatorcontrib><creatorcontrib>Sureda, A</creatorcontrib><creatorcontrib>Mohty, M</creatorcontrib><creatorcontrib>European Society for Blood and Marrow Transplantation (EBMT)</creatorcontrib><creatorcontrib>for the European Society for Blood and Marrow Transplantation (EBMT)</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Passweg, J R</au><au>Baldomero, H</au><au>Bader, P</au><au>Bonini, C</au><au>Cesaro, S</au><au>Dreger, P</au><au>Duarte, R F</au><au>Dufour, C</au><au>Falkenburg, J H F</au><au>Farge-Bancel, D</au><au>Gennery, A</au><au>Kröger, N</au><au>Lanza, F</au><au>Nagler, A</au><au>Sureda, A</au><au>Mohty, M</au><aucorp>European Society for Blood and Marrow Transplantation (EBMT)</aucorp><aucorp>for the European Society for Blood and Marrow Transplantation (EBMT)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><stitle>Bone Marrow Transplant</stitle><addtitle>Bone Marrow Transplant</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>50</volume><issue>4</issue><spage>476</spage><epage>482</epage><pages>476-482</pages><issn>0268-3369</issn><eissn>1476-5365</eissn><abstract>A record number of 39 209 HSCT in 34 809 patients (14 950 allogeneic (43%) and 19 859 autologous (57%)) were reported by 658 centers in 48 countries to the 2013 survey. Trends include: more growth in allogeneic than in autologous HSCT, increasing use of sibling and unrelated donors and a pronounced increase in haploidentical family donors when compared with cord blood donors for those patients without a matched related or unrelated donor. Main indications were leukemias, 11 190 (32%; 96% allogeneic); lymphoid neoplasias, 19 958 (57%; 11% allogeneic); solid tumors, 1543 (4%; 4% allogeneic); and nonmalignant disorders, 1975 (6%; 91% allogeneic). In patients without a matched sibling or unrelated donor, alternative donors are used. Since 2010 there has been a marked increase of 96% in the number of transplants performed from haploidentical relatives (802 in 2010 to 1571 in 2013), whereas the number of unrelated cord blood transplants has slightly decreased (789 in 2010 to 666 in 2013). The use of donor type varies greatly throughout Europe.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>25642761</pmid><doi>10.1038/bmt.2014.312</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0268-3369 |
| ispartof | Bone marrow transplantation (Basingstoke), 2015-04, Vol.50 (4), p.476-482 |
| issn | 0268-3369 1476-5365 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4387247 |
| source | MEDLINE; SpringerLink Journals; Nature; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | 692/699/1541/1990 692/700 Allografts Autografts Bone marrow Care and treatment Cell Biology Cord Blood Stem Cell Transplantation Databases, Factual Europe - epidemiology Female Forecasts and trends Hematology Hematopoietic Stem Cell Transplantation Humans Internal Medicine Leukemia Male Medicine Medicine & Public Health Methods Neoplasms - epidemiology Neoplasms - therapy Public Health Special Report Stem cell transplantation Stem Cells Surveys Tissue donation Unrelated Donors |
| title | Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T00%3A31%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hematopoietic%20SCT%20in%20Europe%202013:%20recent%20trends%20in%20the%20use%20of%20alternative%20donors%20showing%20more%20haploidentical%20donors%20but%20fewer%20cord%20blood%20transplants&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=Passweg,%20J%20R&rft.aucorp=European%20Society%20for%20Blood%20and%20Marrow%20Transplantation%20(EBMT)&rft.date=2015-04-01&rft.volume=50&rft.issue=4&rft.spage=476&rft.epage=482&rft.pages=476-482&rft.issn=0268-3369&rft.eissn=1476-5365&rft_id=info:doi/10.1038/bmt.2014.312&rft_dat=%3Cgale_pubme%3EA409833521%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1667953288&rft_id=info:pmid/25642761&rft_galeid=A409833521&rfr_iscdi=true |